870997-81-2 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Amino-2-methoxy-4-pyridinecarboxylic acid is used as a building block in the synthesis of pharmaceuticals, particularly for the production of anti-tuberculosis and anti-malarial drugs. Its structural and functional attributes contribute to the creation of effective medicinal compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Amino-2-methoxy-4-pyridinecarboxylic acid is utilized as a valuable intermediate due to its unique structure and functional groups, which facilitate the development of a variety of organic compounds.
Used in Molecular Biology and Biochemical Research:
3-Amino-2-methoxy-4-pyridinecarboxylic acid is employed in molecular biology and biochemical research as it has the potential to modulate enzyme activity and protein function, making it a useful tool for studying biological processes and mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 870997-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,0,9,9 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 870997-81:
(8*8)+(7*7)+(6*0)+(5*9)+(4*9)+(3*7)+(2*8)+(1*1)=232
232 % 10 = 2
So 870997-81-2 is a valid CAS Registry Number.
InChI:InChI=1S/C7H8N2O3/c1-12-6-5(8)4(7(10)11)2-3-9-6/h2-3H,8H2,1H3,(H,10,11)
870997-81-2Relevant academic research and scientific papers
Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists
Mizutani, Takashi,Nagase, Tsuyoshi,Ito, Sayaka,Miyamoto, Yasuhisa,Tanaka, Takeshi,Takenaga, Norihiro,Tokita, Shigeru,Sato, Nagaaki
scheme or table, p. 6041 - 6045 (2009/06/30)
Novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives were identified as potent human H3 receptor inverse agonists. After systematic modification of lead 5a, the potent and selective analog 5r was identified. Elimination of hERG K+ channel and human α1A-adrenoceptor activities is the main focus of the present study.
